FdaApplication

ANDA 213568

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA LTD
application_typeANDA
approval_date2026-06-09

Products (2)

ProductActive ingredientStrengthDosage form
CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION;ORAL
CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION;ORAL

2 products